Sentinel lymph node (SLN) biopsy is a rapidly emerging treatment option for the patient with
early stage invasive breast cancer and a clinically negative axilla. In the era of …

Axillary node status is the most important prognostic indicator for patients with invasive
breast cancer. Sentinel lymph-node biopsy (SLNB) is widely accepted and the preferred …

Sentinel lymph node (SLN) biopsy is a useful way of assessing axillary nodal status and
obviating axillary lymph node dissection (ALND) in patients with node‐negative breast …

Opinion statement The status of the axilla is the single most important prognostic indicator of
overall survival in patients with breast cancer. Staging is based on tumor size and on the …

SLN biopsy is the new standard of care for nodal staging in early-stage breast cancer
patients and contraindications are decreasing with experience. However, the clinical …

Axillary node status is a major prognostic factor in early‐stage disease. Traditional staging
needs levels I and II axillary lymph node dissection. Axillary involvement is found in 10 …

BACKGROUND Sentinel lymph node (SLN) mapping and biopsy is emerging as an
alternative to axillary lymph node dissection (ALND) in determining the lymph node status of …

PURPOSE: Recent studies have suggested that the sentinel lymph node (SLN) biopsy is an
accurate alternative staging procedure for women with breast cancer. The goal of this study …

The most powerful predictor of survival in breast cancer is the presence or absence of lymph
node metastases. Lymphatic mapping and sentinel node biopsy is a new technique that …

Background and methods. The objectives of this article are to review existing controversies
regarding sentinel lymph node (SLN) biopsy and to identify potential areas of consensus in …